We caught up with Anthony Sebba (Arthritis Associates, FL, USA) to talk about the results from his study analysing pain and other patient-reported outcomes in patients with rheumatoid arthritis. The abstract ‘Pain and Other Patient-Reported Outcomes in Patients with Rheumatoid Arthritis Who Did or Did Not Achieve Treatment Response Based on Improvement in Swollen Joints in Tocilizumab Clinical Trials.’ (ABSTRACT NUMBER: 1237) was presented at the virtual ACR Convergence 2020, 5-9 November 2020.
Questions
- Could you tell us a little about the study and its findings? (0:06)
Disclosures: Consultant or speaker for Genentech, Sanofi, Lilly, Gilead and Amgen.
Support: Interview and filming supported by Touch Medical Media.
Filmed in coverage of the ACR 2020 Annual Meeting (Virtual).
